SCHEMBL1835704

SCHEMBL1835704

CCOC(=O)C(C)(Cc1ccccc1)NC(=O)CCl

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RECQL P46063 2/20 0.56
ALDH1A1 P00352 2/20 0.56
MMP8 P22894 1/20 0.56
TAAR1 Q96RJ0 2/20 0.46
THRB P10828 1/20 0.44
LMNA P02545 2/20 0.42
MAPT P10636 3/20 0.41
PIN1 Q13526 1/20 0.41
CYP3A4 P08684 2/20 0.41
CYP1A2 P05177 1/20 0.41
PPID Q08752 1/20 0.41
MAPK1 P28482 1/20 0.40
PTPN2 P17706 1/20 0.40
PTPN1 P18031 1/20 0.40
PTPRB P23467 1/20 0.40
ACP1 P24666 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2760540 0.87 ALDH1A1 (0.46) RECQLALDH1A1MMP8TAAR1MAPT
SCHEMBL606869 0.85 ALDH1A1 (0.72) RECQLALDH1A1MMP8TAAR1THRB
SCHEMBL27574238 0.82 ALDH1A1 (0.57) RECQLALDH1A1MMP8LMNAMAPT
SCHEMBL27993635 0.77 MMP8 (0.69) RECQLALDH1A1MMP8TAAR1THRB
SCHEMBL5913849 0.76 CYP3A4 (0.59) RECQLALDH1A1MMP8TAAR1LMNA
SCHEMBL10821760 0.76 MMP8 (0.63) RECQLALDH1A1MMP8TAAR1THRB
SCHEMBL8710582 0.75 MMP8 (0.79) RECQLALDH1A1MMP8TAAR1THRB
SCHEMBL1492859 0.75 MMP8 (0.65) RECQLALDH1A1MMP8TAAR1THRB
SCHEMBL7271605 0.74 MMP8 (0.57) RECQLALDH1A1MMP8THRBLMNA
SCHEMBL7271610 0.74 MMP8 (0.57) RECQLALDH1A1MMP8THRBLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102119153-A Method for preparation of piperazindione derivates BASF SE 2011-07-06 CN disclosed
US-20110144336-A1 Method for Preparation of Piperazindione Derivatives BASF SE (DE) 2011-06-16 US disclosed
EP-2318379-A1 METHOD FOR PREPARATION OF PIPERAZINDIONE DERIVATES BASF SE (DE) 2011-05-11 EP disclosed
WO-2010018067-A1 METHOD FOR PREPARATION OF PIPERAZINDIONE DERIVATES BASF SE (DE) 2010-02-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144336-A1 Method for Preparation of Piperazindione Derivatives H1-0, H1-3, H1-2 RECQL 1157/4885ALDH1A1 705/4885MMP8 4290/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.